Faroalfa CV Tablet is a potent combination antibiotic containing Faropenem 200mg and Clavulanic Acid 125mg, designed to effectively combat a broad spectrum of bacterial infections. Faropenem, a beta-lactam antibiotic belonging to the penem class, exhibits strong bactericidal activity by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing bacterial enzymes from breaking down Faropenem, thereby enhancing its efficacy against resistant strains. This synergistic combination makes Faroalfa CV particularly effective in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by both Gram-positive and Gram-negative organisms. The tablet formulation ensures convenient oral administration with good bioavailability. Faroalfa CV is generally well-tolerated, but patients should be monitored for potential side effects such as gastrointestinal disturbances or allergic reactions. It is essential to use this medication under medical supervision to avoid misuse and resistance development. Faroalfa CV Tablet offers a reliable therapeutic option for managing infections where resistance to conventional antibiotics is a concern, ensuring improved patient outcomes through its broad-spectrum antibacterial action.